Circulating levels of insulin-like growth factor-I and risk of ovarian cancer

International Journal of Cancer

Volumn 101, Issue 6, 2002, Pages 549-554

  Lukanova, Annekatrin ^a,b   Lundin, Eva ^b   Toniolo, Paolo ^c   Micheli, Andrea ^d   Akhmedkhanov, Arslan ^c   Rinaldi, Sabina ^a   Muti, Paola ^e   Lenner, Per ^f   Biessy, Carine ^a   Krogh, Vittorio ^d   Zeleniuch Jacquotte, Anne ^c   Berrino, Franco ^d   Hallmans, Göran ^b   Riboli, Elio ^a   Kaaks, Rudolf ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UMEÅ UNIVERSITY   (Sweden)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY AT BUFFALO   (United States)

^f UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cohort study; Insulin like growth factor binding protein 3; Insulin like growth factor I; Ovarian cancer

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD DONOR; BLOOD LEVEL; CANCER RISK; CELL PROLIFERATION; CIGARETTE SMOKING; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MITOGENICITY; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

AGE FACTORS; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 0037145317     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10613     Document Type: Article

References (35)

1. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971;2:163.
2. Gardner W. Hormonal imbalances in tumorigenesis. Cancer Res 1948;8:397-411.
3. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-21.
4. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, Comstock GW. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995;274:1926-30.
5. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999;91:1459-67.
6. Weiss NS, Cook LS, Farrow DC, Rosenblatt KA. Ovarian cancer. In: Schottenfeld D, Fraumeni FJ, editors. Cancer epidemiology and prevention. 2 ed. Oxford: Oxford University Press; 1996. p. 1040-57.
7. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-86.
8. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
9. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, Shore RE, Zeleniuch-Jacquotte A. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000;88:828-32.
10. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 2000;92:1910-7.
11. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-6.
12. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620-5.
13. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, Kaaks R. Plasma IGF-I, IGF-binding protein-3 and risk of colorectal cancer: A prospective study in northern Sweden. Gut 2002;50:642-6.
14. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-89.
15. Kuroda H, Mandai M, Konishi I, Tsuruta Y, Kusakari T, Kariya M, Fujii S. Human ovarian surface epithelial (OSE) cells express LH/hCG receptors, and hCG inhibits apoptosis of OSE cells via upregulation of insulin-like growth factor-1. Int J Cancer 2001;91:309-15.
16. Resnicoff M, Ambrose D, Coppola D, Rubin R. Insulin-like growth factor-I and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Invest 1993;69:756-60.
17. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000;21:215-44.
18. Karasik A, Menczer J, Pariente C, Kanety H. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab 1994;78:271-6.
19. Conover CA, Hartmann LC, Bradley S, Stalboerger P, Klee GG, Kalli KR, Jenkins RB. Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. Exp Cell Res 1998;238:439-49.
20. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 1997;82:2308-13.
21. Katsaros D, Yu H, Levesque MA, Danese S, Genta F, Richiardi G, Fracchioli S, Khosravi MJ, Diamandi A, Gordini G, Diamandis EP, Massobrio M. IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival. Eur J Cancer 2001;37:478-85.
22. Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schunemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16α-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 2000;11:635-40.
23. Kato I, Toniolo P, Koenig KL, Kahn A, Schymura M, Zeleniuch-Jacquotte A. Comparison of active and cancer registry-based follow-up for breast cancer in a prospective cohort study. Am J Epidemiol 1999;149:372-8.
24. SAS Institute. SAS/STATR User's Guide Version 6. SAS Manual 1990;4.
25. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
26. Goodman GD, Barrett CE. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-6.
27. Kaaks R, Soderberg S, Olsson T, Hallmans G, Stattin P. Re: Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 2001;93:650-1.
28. Coppola D, Saunders B, Fu L, Mao W, Nicosia SV. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression. Cancer Res 1999;59:3264-70.
29. Lund PK. Insulin-like growth factors: gene structure and regulation. In: Kostyo JL, Goodman HM, editors. Hormonal control of growth. 1st ed. New York: Oxford University Press; 1999. p. 537-71.
30. Urban RJ, Garmey JC, Shupnik MA, Veldhuis JD. Insulin-like growth factor type I increases concentrations of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage enzyme in primary cultures of porcine granulosa cells. Endocrinology 1990;127:2481-8.
31. Magoffin DA, Weitsman SR. Insulin-like growth factor-I stimulates the expression of 3 β-hydroxysteroid dehydrogenase messenger ribonucleic acid in ovarian theca-interstitial cells. Biol Reprod 1993;48:1166-73.
32. deMoura MD, Choi D, Adashi EY, Payne DW. Insulin-like growth factor-I-mediated amplification of follicle-stimulating hormone-supported progesterone accumulation by cultured rat granulosa cells: enhancement of steroidogenic enzyme activity and expression. Biol Reprod 1997;56:946-53.
33. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001;60:91-106.
34. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000;60:3744-8.
35. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.